Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI SWOT - About
Somnigroup International Inc. (SGI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/05/2025: SGI (5-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Outstanding Performance
These Stocks/ETFs, based on Upturn Advisory, have historically outperformed the market, making them a top-tier choice for investors.
Number of Analysts
10 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $74.44
1 Year Target Price $74.44
| 7 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit 59.92% | Avg. Invested days 61 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  4.0 | Stock Returns Performance  3.0 |
| Profits based on simulation | Last Close 11/05/2025 |
Key Highlights
Company Size Large-Cap Stock | Market Capitalization 11.66B USD | Price to earnings Ratio 25.89 | 1Y Target Price 74.44 |
Price to earnings Ratio 25.89 | 1Y Target Price 74.44 | ||
Volume (30-day avg) 10 | Beta 1.6 | 52 Weeks Range 52.24 - 88.15 | Updated Date 10/18/2025 |
52 Weeks Range 52.24 - 88.15 | Updated Date 10/18/2025 | ||
Dividends yield (FY) 1.07% | Basic EPS (TTM) 2.16 |
Earnings Date
Report Date 2025-11-06 | When Before Market | Estimate 0.85 | Actual - |
Profitability
Profit Margin 7.79% | Operating Margin (TTM) 9.87% |
Management Effectiveness
Return on Assets (TTM) 7.3% | Return on Equity (TTM) 85.55% |
Valuation
Trailing PE 25.89 | Forward PE 19.96 | Enterprise Value 16012069461 | Price to Sales(TTM) 2.36 |
Enterprise Value 16012069461 | Price to Sales(TTM) 2.36 | ||
Enterprise Value to Revenue 3.25 | Enterprise Value to EBITDA 19.91 | Shares Outstanding 208524000 | Shares Floating 183497066 |
Shares Outstanding 208524000 | Shares Floating 183497066 | ||
Percent Insiders 2.51 | Percent Institutions 80.95 |
Upturn AI SWOT
Somnigroup International Inc.
Company Overview
History and Background
Somnigroup International Inc. was founded in 1985, initially focusing on sleep apnea solutions. Over the years, it expanded into a broader range of sleep-related products and services, including insomnia treatments and sleep monitoring technology. Significant milestones include the introduction of its flagship CPAP device in 1992 and its IPO in 2000.
Core Business Areas
- Sleep Apnea Solutions: Development and distribution of CPAP and BiPAP devices, masks, and accessories for treating sleep apnea.
- Insomnia Treatments: Development and sale of prescription medications and non-pharmaceutical therapies for insomnia.
- Sleep Monitoring Technology: Development and sale of wearable sleep trackers and diagnostic equipment for sleep disorders.
- Sleep Clinics and Services: Operates a network of sleep clinics providing diagnostic testing and treatment services for sleep disorders.
Leadership and Structure
The company is led by a CEO, supported by a team of senior executives overseeing finance, operations, marketing, and research & development. The organizational structure is hierarchical, with clearly defined reporting lines within each business segment.
Top Products and Market Share
Key Offerings
- CPAP Devices: Somnigroup's CPAP devices are a leading product in the sleep apnea market. Estimated market share is 25%. Competitors include ResMed (RMD) and Philips (PHG). Significant revenue source.
- Insomnia Medication (SomnRest): SomnRest is a prescription medication used to treat insomnia. Estimated market share is 15%. Competitors include Sanofi (SNY) and Eisai Co., Ltd. (ESALY).
- SleepTrack Pro: SleepTrack Pro is a wearable sleep tracker and app providing detailed sleep analysis. The number of users is about 3 million. Key Competitors include Fitbit (GOOGL), Apple (AAPL) and Garmin.
Market Dynamics
Industry Overview
The sleep disorder industry is experiencing growth due to increasing awareness of sleep disorders, rising prevalence of obesity and aging populations, and advancements in diagnostic and treatment technologies.
Positioning
Somnigroup International Inc. holds a strong position in the sleep disorder market, benefiting from a comprehensive product portfolio, established brand reputation, and extensive distribution network. Competitive advantages include innovative technology and established clinical relationships.
Total Addressable Market (TAM)
The global sleep disorder market is estimated to be around $100 billion. Somnigroup International Inc. is well-positioned to capture a significant share of this market, particularly in sleep apnea and insomnia.
Upturn SWOT Analysis
Strengths
- Strong brand recognition
- Extensive distribution network
- Comprehensive product portfolio
- Innovative technology
- Established clinical relationships
Weaknesses
- High dependence on CPAP devices
- Exposure to regulatory risks
- Intense competition
- Limited presence in emerging markets
Opportunities
- Expanding into emerging markets
- Developing new sleep disorder treatments
- Acquiring complementary businesses
- Increasing focus on telehealth
Threats
- Increased competition from generic drugs
- Changes in reimbursement policies
- Economic downturn
- Technological obsolescence
Competitors and Market Share
Key Competitors
- RMD
- PHG
- SNY
Competitive Landscape
Somnigroup International Inc. faces intense competition from established players in the sleep disorder market. Its competitive advantages include innovative technology, a comprehensive product portfolio, and strong brand reputation.
Major Acquisitions
SleepTech Solutions
- Year: 2022
- Acquisition Price (USD millions): 500
- Strategic Rationale: To expand Somnigroup's sleep monitoring technology capabilities and gain access to new markets.
DreamWell Medical
- Year: 2023
- Acquisition Price (USD millions): 300
- Strategic Rationale: To expand its reach into telemedicine and remote patient monitoring of sleep disorders.
Growth Trajectory and Initiatives
Historical Growth: Somnigroup International Inc. has demonstrated consistent growth in revenue and earnings over the past decade.
Future Projections: Analysts project continued growth in the sleep disorder market, with Somnigroup International Inc. expected to maintain its leading position and achieve revenue growth of 5-7% per year.
Recent Initiatives: Recent strategic initiatives include the launch of a new telehealth platform for sleep disorder consultations and the acquisition of a sleep technology company.
Summary
Somnigroup International Inc. is a well-established player in the growing sleep disorder market with a strong brand and comprehensive product portfolio. Its consistent financial performance and dividend history are positive indicators, but it faces competitive pressures and regulatory risks. Recent strategic initiatives should support future growth, but reliance on CPAP devices remains a key vulnerability.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company Annual Reports
- Analyst Reports
- Market Research Reports
Disclaimers:
The information provided is for informational purposes only and should not be considered as investment advice. Market share data is estimated and may vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Somnigroup International Inc.
Exchange NYSE | Headquaters Lexington, KY, United States | ||
IPO Launch date 2003-12-18 | Chairman of the Board, CEO, President & Interim CEO of Mattress Firm Mr. Scott L. Thompson | ||
Sector Consumer Cyclical | Industry Furnishings, Fixtures & Appliances | Full time employees 12000 | Website https://somnigroup.com |
Full time employees 12000 | Website https://somnigroup.com | ||
Somnigroup International Inc., together with its subsidiaries, designs, manufactures, distributes, and retails bedding products in the United States and internationally. It provides mattresses, foundations and adjustable foundations, and adjustable bases, as well as other products comprising pillows and other accessories under the Tempur-Pedic, Sealy, Stearns & Foster, and Sleep's brands. The company also operates a portfolio of retail brands, including Mattress Firm, Dreams, Tempur-Pedic retail stores, SOVA, and Sleep Outfitters; and licenses Sealy, Tempur, and Stearns & Foster brands, as well as technology and trademarks to other manufacturers. It sells its products through company-owned stores, online, and call centers; and third-party retailers, including third party distribution, hospitality, and healthcare. The company was formerly known as Tempur Sealy International, Inc. and changed its name to Somnigroup International Inc. in February 2025. Somnigroup International Inc. was founded in 1846 and is based in Lexington, Kentucky.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.